Advertisement
News
Subscribe to Drug Discovery & Development News

The Lead

New Model for Combatting the Ebola Epidemic

January 26, 2015 | by Columbia University | Comments

An ICAP team conducted a three-week rapid assessment of Ebola community care centers. Read more...                           

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Neural Spines Operate Like Miniature Neurons

January 26, 2015 11:04 am | by LMU | Comments

A recent study by teams of neurobiologists based at LMU and Regensburg addresses the role of the short protrusions called “spines” that form on the dendrites of nerve cells in the mammalian olfactory bulb. Dendrites serve as receptors for signals delivered by the so-called axons of other neurons. Read more...

TOPICS:

Shire's Hunter Syndrome Treatment Gains FDA Fast Track Designation

January 26, 2015 10:59 am | Comments

Shire's drug treats the neurocognitive decline associated with Hunter syndrome. Read more...                           

TOPICS:

GSK Expands Portfolio of Asthma/COPD Medicines in U.S.

January 26, 2015 10:55 am | by GSK | Comments

GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the U.S. Read more...                             

TOPICS:
Advertisement

Study Finds Potential New Drug Target for Lung Cancer

January 26, 2015 10:46 am | by Kentucky University | Comments

A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer. Read more...              

TOPICS:

How Cancer Turns Good Cells to the Dark Side

January 26, 2015 10:39 am | by Rice University | Comments

Cancer uses a little-understood element of cell signaling to hijack the communication process and spread, according to Rice University researchers. Read more...                             

TOPICS:

Tide Turning in Ebola Fight After Hard Lessons

January 26, 2015 10:34 am | by Associated Press | Comments

A top U.N. official in the fight against Ebola greeted just three patients at one treatment center he visited this week in Sierra Leone. Families in Liberia are no longer required to cremate the remains of loved ones to halt the spread of the virulent disease. Read more...

TOPICS:

Regeneron, Sanofi: FDA Accepts BLA for Hyperchoestrolemia Drug

January 26, 2015 10:20 am | by Sanofi | Comments

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for PraluentTM (alirocumab). Under the Prescription Drug User Fee Act (PDUFA), the goal for a priority review is six months, for a target action date of July 24, 2015. Read more...

TOPICS:

WHO Adopts Reforms to Repair Reputation After Ebola

January 26, 2015 10:07 am | Comments

The World Health Organization has proposed reforms that could overhaul its structure after botching the response to the biggest-ever Ebola outbreak, a sluggish performance that experts say cost thousands of lives. Read more...                                    

TOPICS:
Advertisement

FDA Approves Prestalia's Hypertension Treatment

January 26, 2015 10:00 am | by Prestalia | Comments

Symplmed Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Prestalia (perindopril arginine and amlodipine) tablets, licensed from Servier (Suresnes, France), for the treatment of hypertension.           

TOPICS:

Added Protections for Consumer Info on Health Website

January 26, 2015 9:56 am | by Associated Press | Comments

The Obama administration appears to be making broader changes to protect consumer information on the government's health insurance website, after objections from lawmakers and privacy advocates. Read more...                 

TOPICS:

Medical Pot Only OK for Sick Kids Failed by Other Drugs: MDS

January 26, 2015 9:52 am | by Lindsey Tanner, AP Medical Writer - Associated Press | Comments

With virtually no hard proof that medical marijuana benefits sick children, and evidence that it may harm developing brains, the drug should only be used for severely ill kids who have no other treatment option, the nation's most influential pediatricians group says in a new policy. Read more...

TOPICS:

Meningococcal Vaccine Gets FDA Approval

January 26, 2015 9:44 am | by FDA | Comments

The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Read more..                       

TOPICS:

FDA Clears Roche's MRSA/SA Test

January 26, 2015 9:32 am | by Roche | Comments

Roche announced that the US Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas MRSA/SA Test for the early, simultaneous detection of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (SA) directly from nasal specimens. Read more...

TOPICS:

Potential Hydrogen Sulfide Poisoning Therapy Being Investigated

January 23, 2015 4:02 pm | by Iowa State University | Comments

Researchers are investigating the long-term neurological damage caused by hydrogen sulfide poisoning. Read more...                         

TOPICS:

Scientists Find Gene Vital to Central Nervous System Development

January 23, 2015 3:53 pm | by Julia Evangelou Strait, Washington University in St. Louis | Comments

Scientists have identified a gene that helps regulate how well nerves of the central nervous system are insulated. Read more...                      

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading